Open AccessComparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe
Author(s) -
Kate Soldan,
Joakim Dillner
Publication year - 2006
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.11.47.03085-en
Subject(s) - human papillomavirus vaccine , human papillomavirus , virology , medicine , gardasil , cervical cancer , cancer
A quadrivalent vaccine against human papillomavirus types 16, 18, 6 and 11, known as Gardasil was granted a marketing license by the European Commission in September 2006
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom